Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for Swedish Orphan Biovitrum
Explore 22 clinical trials worldwide
Search
Showing 1-22 of 22 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: Swedish Orphan Biovitrum
Clinical Trials (22)
NCT07148947
Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms
PHASE2
Not yet recruiting
27 participants
Started: Feb 1, 2026 · Completed: Dec 31, 2028
2 conditions
2 sponsors
1 location
NCT06227429
A Non-interventional, Post-Marketing Study to Describe Outcome of Nitisinone Treatment in HT-1 Patients
N/A
Recruiting
15 participants
Started: Sep 30, 2025 · Completed: Jun 30, 2027
1 condition
1 sponsor
4 locations
NCT06666335
A Study to Evaluate Efficacy and Safety of Anakinra in Chinese Patients With Colchicine-resistent FMF
PHASE4
Not yet recruiting
3 participants
Started: Sep 1, 2025 · Completed: Nov 30, 2027
1 condition
2 sponsors
0 locations
NCT06992505
Assessment of Macrophage Activation syndromE in STill's Disease in Italy
N/A
Recruiting
35 participants
Started: Jun 6, 2025 · Completed: Sep 30, 2025
3 conditions
1 sponsor
2 locations
NCT06782373
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
PHASE2
Recruiting
78 participants
Started: May 28, 2025 · Completed: Aug 31, 2027
2 conditions
2 sponsors
40 locations
NCT06940830
Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa
PHASE4
Recruiting
250 participants
Started: May 21, 2025 · Completed: Dec 31, 2028
1 condition
2 sponsors
21 locations
NCT06716814
Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa
PHASE3
Recruiting
104 participants
Started: Mar 6, 2025 · Completed: Mar 31, 2027
1 condition
2 sponsors
22 locations
NCT06579144
Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A
PHASE1
Recruiting
24 participants
Started: Feb 24, 2025 · Completed: Oct 28, 2025
1 condition
2 sponsors
7 locations
NCT06538181
Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome
PHASE1
Recruiting
15 participants
Started: Feb 13, 2025 · Completed: Feb 28, 2029
3 conditions
2 sponsors
1 location
NCT06752850
A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis
PHASE4
Recruiting
35 participants
Started: Dec 19, 2024 · Completed: Dec 31, 2026
6 conditions
2 sponsors
10 locations
NCT06550141
Emapalumab Prevention of CAR-T Cell Associated Toxicities
PHASE2
Recruiting
28 participants
Started: Sep 18, 2024 · Completed: Aug 1, 2027
7 conditions
2 sponsors
2 locations
NCT06352216
Prevalence of Synovitis in Patients With Haemophilia A
N/A
Recruiting
300 participants
Started: Apr 15, 2024 · Completed: Mar 31, 2027
4 conditions
2 sponsors
1 location
NCT05772546
Avatrombopag vs. Placebo for CIT in GI Malignancies
PHASE2
Recruiting
60 participants
Started: Nov 1, 2023 · Completed: Jul 31, 2026
3 conditions
2 sponsors
4 locations
NCT04656184
A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
PHASE3
Recruiting
84 participants
Started: Oct 20, 2023 · Completed: Mar 31, 2027
1 condition
2 sponsors
1 location
NCT05817812
A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa
PHASE3
Active, not recruiting
93 participants
Started: Jul 31, 2023 · Completed: Jun 12, 2026
1 condition
2 sponsors
30 locations
NCT05776472
A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
N/A
Recruiting
200 participants
Started: Jun 26, 2023 · Completed: Aug 15, 2029
1 condition
2 sponsors
75 locations
NCT05814159
A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)
PHASE3
Active, not recruiting
15 participants
Started: Aug 24, 2022 · Completed: Jun 24, 2026
2 conditions
2 sponsors
8 locations
NCT05152238
ITP Registry and Accompanying Biospecimen Collection
N/A
Recruiting
1,100 participants
Started: Nov 29, 2021 · Completed: Apr 30, 2027
1 condition
7 sponsors
64 locations
NCT04293523
A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health
N/A
Active, not recruiting
427 participants
Started: Mar 30, 2020 · Completed: Apr 30, 2026
1 condition
1 sponsor
53 locations
NCT03587701
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
PHASE2
Recruiting
57 participants
Started: Jan 3, 2019 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT03165734
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
PHASE3
Recruiting
399 participants
Started: Jun 26, 2017 · Completed: Jul 30, 2027
3 conditions
2 sponsors
207 locations
NCT01746849
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
PHASE2
Active, not recruiting
82 participants
Started: Dec 31, 2012 · Completed: Dec 31, 2025
4 conditions
2 sponsors
1 location